Fosaprepitant Dimeglumine 55150-0299-01
- Manufacturer
- Eugia Us Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 12, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA210625
Need to source Fosaprepitant Dimeglumine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fosaprepitant Dimeglumine | 150 mg/5mL |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
55150-0299-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01) / 5 mL in 1 VIAL, SINGLE-DOSE